DE69629519D1 - Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung - Google Patents

Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung

Info

Publication number
DE69629519D1
DE69629519D1 DE69629519T DE69629519T DE69629519D1 DE 69629519 D1 DE69629519 D1 DE 69629519D1 DE 69629519 T DE69629519 T DE 69629519T DE 69629519 T DE69629519 T DE 69629519T DE 69629519 D1 DE69629519 D1 DE 69629519D1
Authority
DE
Germany
Prior art keywords
wound
iodine
complex
healing
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629519T
Other languages
English (en)
Other versions
DE69629519T2 (de
Inventor
Arun B Kulkarni
Gregory R Skover
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Products Inc
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Products Inc, Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Products Inc
Application granted granted Critical
Publication of DE69629519D1 publication Critical patent/DE69629519D1/de
Publication of DE69629519T2 publication Critical patent/DE69629519T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Materials For Medical Uses (AREA)
DE69629519T 1995-06-07 1996-06-06 Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung Expired - Lifetime DE69629519T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48726095A 1995-06-07 1995-06-07
US487260 1995-06-07

Publications (2)

Publication Number Publication Date
DE69629519D1 true DE69629519D1 (de) 2003-09-25
DE69629519T2 DE69629519T2 (de) 2004-06-24

Family

ID=23935020

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629519T Expired - Lifetime DE69629519T2 (de) 1995-06-07 1996-06-06 Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung

Country Status (9)

Country Link
US (1) US6025446A (de)
EP (1) EP0747062B1 (de)
JP (1) JP4416844B2 (de)
CN (1) CN1089587C (de)
AT (1) ATE247487T1 (de)
AU (1) AU722246B2 (de)
BR (1) BR9602671A (de)
CA (1) CA2178458C (de)
DE (1) DE69629519T2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2976697A (en) * 1996-05-31 1998-01-05 Fuji Yakuhin Kogyo Kabushiki Kaisha Iodine-containing highly water-absorbent fibers
AU4699799A (en) 1998-06-19 2000-01-05 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
DE60037657T2 (de) * 1999-06-04 2009-01-08 Oxibio, Inc., Portland Infektionsmittel enthaltendes medizinisches gerät und verfahren zu ihrer darstellung
EP1813293A3 (de) * 1999-06-04 2007-10-03 Oxibio, Inc. Antiinfektiöse medizinische Vorrichtung und Verfahren zu ihrer Herstellung
US6838050B1 (en) 1999-06-04 2005-01-04 Oxibio, Inc. Methods and devices for providing anti-infective activity to a medical device
US6592890B1 (en) 1999-10-20 2003-07-15 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
US6582683B2 (en) 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
NL1016776C2 (nl) * 2000-12-01 2002-06-04 Julia Caussin Samenstelling voor toepassing bij brandwonden, schaafwonden en schrammen.
US6756059B2 (en) 2001-08-20 2004-06-29 Skinvisible Pharmaceuticals, Inc. Topical composition, topical composition precursor, and methods for manufacturing and using
US20030144362A1 (en) * 2002-01-28 2003-07-31 Utterberg David S. High viscosity antibacterials for cannulae
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US7659344B2 (en) * 2006-06-08 2010-02-09 E. I. Du Pont De Nemours And Company Shaped articles containing poly(vinylpyrrolidone)-iodine complex
US7692892B2 (en) * 2006-07-19 2010-04-06 Seagate Technology Llc Two-material base for a data storage system
US8128913B1 (en) 2007-12-06 2012-03-06 Skinvisible Pharmaceuticals, Inc. Sunscreen composition with enhanced UV-A absorber stability and methods
US8299122B2 (en) 2008-04-14 2012-10-30 Skinvisible Pharmaceuticals, Inc. Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
US20140072525A1 (en) * 2012-09-07 2014-03-13 Gaab, Llc Antimicrobial preparation and methods for making and using the same
WO2015198290A1 (es) * 2014-06-27 2015-12-30 Inversiones E Innovaciones Capel S.A.S. Composiciones microbicidas incoloras que comprenden un yodóforo
WO2016179575A1 (en) 2015-05-07 2016-11-10 Kci Liensing, Inc. A controlled release iodine structure for use with wound care
WO2016209966A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
CN109620842B (zh) * 2019-02-02 2021-05-04 上海宇昂水性新材料科技股份有限公司 交联聚乙烯吡咯烷酮和碘的络合物及其制备方法与应用
GB2588440A (en) * 2019-10-24 2021-04-28 Io Cyte Ltd Swellable antimicrobial fibre
GB2588442A (en) * 2019-10-24 2021-04-28 Io Cyte Ltd Antimicrobial material
CA3074150A1 (en) 2020-02-18 2021-08-18 Ovation Science, Inc. Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc)
CN111593326B (zh) * 2020-06-05 2022-01-28 西北工业大学 一种化学气相沉积法制备碘固定高分子涂层的方法及应用
CN113437339A (zh) * 2021-05-10 2021-09-24 中国科学院金属研究所 一种用于锌碘液流电池的正极电解液
CN115093509B (zh) * 2022-04-21 2024-01-19 中山大学附属第八医院（深圳福田） 一种具有自润滑和抗菌性能的超高分子量聚乙烯材料及其制备方法和应用
CN116120491B (zh) * 2022-12-28 2024-03-22 成都科宏达化学有限责任公司 一种利用粗碘制备聚维酮碘的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687855A (en) * 1969-05-05 1972-08-29 Synergistics Inc Solid iodophor cleansing compositions
DE2054140B2 (de) * 1969-11-10 1979-05-10 Gaf Corp., New York, N.Y. (V.St.A.) Jod-Komplex eine Polymers
YU193875A (en) * 1974-08-16 1982-02-28 Basf Ag Process for producing polyvinyl pyrrolidone-iodine
GB1514324A (en) * 1975-07-21 1978-06-14 Johansson J Disinfectant and a method of preparing the same
IT1230566B (it) * 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
AU4113993A (en) * 1992-04-30 1993-11-29 Isp Investments Inc. Strongly swellable, moderately crosslinked polyvinylpyrrolidone
US5242985A (en) * 1992-06-17 1993-09-07 Isp Investments Inc. Aqueous stable complex of a strongly swellable, moderately crosslinked polyvinylpyrrolidone and iodine
JP3583166B2 (ja) * 1994-06-27 2004-10-27 興和株式会社 損傷皮膚修復用粉末製剤

Also Published As

Publication number Publication date
CA2178458A1 (en) 1996-12-08
EP0747062B1 (de) 2003-08-20
DE69629519T2 (de) 2004-06-24
CN1146338A (zh) 1997-04-02
JPH09100235A (ja) 1997-04-15
CN1089587C (zh) 2002-08-28
BR9602671A (pt) 1998-10-06
JP4416844B2 (ja) 2010-02-17
AU5464896A (en) 1996-12-19
EP0747062A2 (de) 1996-12-11
CA2178458C (en) 2008-01-22
EP0747062A3 (de) 1997-08-06
AU722246B2 (en) 2000-07-27
ATE247487T1 (de) 2003-09-15
US6025446A (en) 2000-02-15

Similar Documents

Publication Publication Date Title
DE69629519D1 (de) Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung
CA1158548A (en) Contact lens disinfecting and preserving solution (polymeric)
DE60117043D1 (de) Behandlung von mukositis
DK0645150T3 (da) Medicinske indretninger underkastet udløst nedbrydning
ATE358500T1 (de) Metallverbindungen enthaltende antimikrobielle wundauflagen
GR1002807B (el) Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
DE69917285D1 (de) Stabilisierte zusammensetzungen mit antibakterieller wirksamkeit
MXPA04003211A (es) Formulaciones de gel hidroalcoholicas y desinfectantes para la piel de accion suave.
JPH02299662A (ja) 抗微生物性製品および組成物
SE7608812L (sv) Antiseptiska kompositioner
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69329448D1 (de) Pharmazeutisches Produkt
AR036747A1 (es) Productos para la axila, con componente de bloque de agua
ES2210404T3 (es) Sistema de neutralizacion doble para tratamiento con yodo de lentes de contacto.
BR9810074A (pt) Panos antimicrobianos suaves
JPS6157515A (ja) 殺ビールス剤
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
WO2004028255A1 (en) Antimicrobial compositions
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
WO2004028400A3 (en) Medical pad, and method for making and using
CN109620842B (zh) 交联聚乙烯吡咯烷酮和碘的络合物及其制备方法与应用
BR0114104A (pt) Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida
HU913884D0 (en) Microbicide preparations containing 4,5-dichlorous-2-cyclohexyl-3-izotiazolone and microbicidal active agents
PT1233748E (pt) Associacao de retinal e aldeidos com actividade antifungica
HUP0400015A2 (en) Pharmaceutical combinations especially for the treatment and prevention of urologigal infections and their extragenital complications

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN